DISCOVER OUR CLINIC

Founded in 1989, Biotrial works with pharmaceutical and biotechnology companies to perform drug evaluations and research new medications. The results of our healthy volunteer studies in both North America and France have directly contributed to the development of new drugs in critical therapeutic areas including diabetes, obesity, venous insufficiency, pain, and infectious diseases. On average, we conduct 80 clinical studies per year.

In the United States, healthy volunteer studies are performed in our state-of-the-art clinical research facilities in Newark, New Jersey, a 60,500 square foot building completed in 2015 now serving as our North American headquarters. We work with both in-house and external medical staff.

HEALTH AND SECURITY FIRST

At Biotrial, we are always looking out for the health and safety of our volunteers. Biotrial studies are prepared by a highly qualified medical team and are carried out in full compliance with the Food & Drug Administration (FDA). An independent review committee called an Institutional Review Board (IRB) evaluates each and every clinical trial to ensure it adheres to the highest safety and ethical standards and to protect the rights and well-being of the participating individuals.

The first thing potential volunteers encounter at Biotrial is the "Informed Consent Process," during which they learn about the study design, the known side-effects of the medication being tested, the reasons for performing a medical research study, the requirements for participation, and any potential risks of participating. This consent will be carefully discussed with a physician. Following the Informed Consent Process, every potential volunteer receives a thorough medical examination prior to any participation in a study in order to verify his or her medical eligibility.

We promise to give you all the information you need to comfortably participate in our trials and be an active part of their success. We are always here to answer your questions.

Volunteers are essential in shaping the future of medicine. We hope you’ll participate in a study with us soon.